Jessica B. Langbaum - Concepedia

Author

Jessica B. Langbaum

Also Known As

C. Ramos, Henao, Eliana, J. B. S. Langbaum, J. Langbaum, J.B. Langbaum, J.B.S. Langbaum, Jessica B Langbaum, Jessica B. Langbaum, Jessica B. S. Langbaum, Jessica B.S. Langbaum

216

Publications

7.1K

Citations

H-Index

Concepts

All Affiliations

Banner Alzheimer’s Institute Alzheimer's Association University of Arizona Arizona State University Translational Genomics Research Institute

About

Jessica B. Langbaum is an author at Banner Alzheimer’s Institute specializing in medicine, neurology, and alzheimer's disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	25	3K
2	Health Sciences	9	9	1.4K
3	Nursing	2	2	72
4	Arts	1	1	18
5	Public Health	1	1	18

Jessica B. Langbaum

Publications

Citations

H-Index

Page 1

	Year	Citations
Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease Eric M. Reiman, Kewei Chen, Xiaofen Liu, Proceedings of the National Academy of Sciences Fibrillar Amyloid-β BurdenNeurochemical BiomarkersGeriatric NeurologyAlzheimer's DiseaseNeurology	2009	791
Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study Eric M. Reiman, Yakeel T. Quiroz, Adam Fleisher, The Lancet Neurology Neuroimaging BiomarkersYoung AdultsAlzheimer's DiseaseDementiaBiomarkers	2012	536
Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI) Jessica B. Langbaum, Kewei Chen, Wendy Lee, NeuroImage Positron Emission TomographyNeuroimaging BiomarkersNeurodegenerative DiseasesAlzheimer's DiseaseHealth Sciences	2009	275
Florbetapir PET analysis of amyloid-β deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional study Adam Fleisher, Kewei Chen, Yakeel T. Quiroz, The Lancet Neurology Neurodegenerative DiseasesAlzheimer's DiseaseFlorbetapir Pet AnalysisBiomarkersAmyloid-β Deposition	2012	226
Resting-state BOLD networks versus task-associated functional MRI for distinguishing Alzheimer's disease risk groups Adam Fleisher, Ayesha Sherzai, Curtis Taylor, NeuroImage Neuroimaging BiomarkersBrain FunctionDisease Risk GroupsMedicineDementia	2009	217
Chronic divalproex sodium use and brain atrophy in Alzheimer disease Adam Fleisher, Diana Truran, J.T. Mai, Neurology	2011	167
Associations Between Biomarkers and Age in the Presenilin 1 E280A Autosomal Dominant Alzheimer Disease Kindred Adam Fleisher, Kewei Chen, Yakeel T. Quiroz, JAMA Neurology	2015	167
Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: Findings from the Alzheimer's Disease Neuroimaging Initiative Kewei Chen, Jessica B. Langbaum, Adam Fleisher, NeuroImage Probable AlzheimerAlzheimer's DiseaseAgingDisease Neuroimaging InitiativeDementia	2010	167
Characterizing Alzheimer's disease using a hypometabolic convergence index Kewei Chen, Napatkamon Ayutyanont, Jessica B. Langbaum, NeuroImage Alzheimer's DiseaseDementiaVascular DementiaHypometabolic Convergence IndexNeurology	2011	161
APOE-related risk of mild cognitive impairment and dementia for prevention trials: An analysis of four cohorts Jing Qian, Frank J. Wolters, Alexa Beiser, PLoS Medicine	2017	156

Page 1